TurboVets is fully live. For support, please submit tickets in app.
Sign In to TurboVets
Your Data is Protected. Never Sold. Never Used for Profit.
Read our FAQ
6014
§ 4.79 Schedule of ratings—eye.

Eye or orbit cancer

Cancerous tumor in the eye, eye socket, or surrounding structures.

What the rating means

VA rates malignant neoplasms of the eye, orbit, and adnexa (excluding skin cancers) under diagnostic code 6014. The rating depends on the kind of treatment your cancer requires.

If your cancer requires treatment comparable to what is used for systemic malignancies — meaning systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation — VA assigns a 100% rating. That 100% rating continues after treatment ends. Six months after treatment stops, VA will schedule a mandatory examination to determine the appropriate rating going forward. Any rating change after that exam follows the rules in 38 CFR § 3.105(e).

If your cancer does not require that level of treatment, VA does not assign a single combined rating under this code. Instead, VA separately evaluates your visual impairment and any nonvisual impairment — such as disfigurement, rated under diagnostic code 7800 — and then combines those separate evaluations. If there has been no local recurrence or metastasis, VA evaluates based on residuals.

Evidence that helps

The type of treatment you received is central to how VA rates this condition, so treatment records are critical. Oncology records, surgical operative reports, radiation therapy records, and chemotherapy administration records can show whether your treatment met the threshold of systemic chemotherapy, X-ray therapy more extensive than to the area of the eye, or surgery more extensive than enucleation.

If your cancer did not require that level of treatment, or after the 100% rating period ends and VA evaluates residuals, two separate lines of evidence matter. For visual impairment, eye examination findings that document your current level of vision in the affected eye are relevant. For nonvisual impairment such as disfigurement, photographs and clinical descriptions of the affected area can document what remains after treatment.

Statements from you or people who know you describing how your remaining symptoms affect your ability to work and carry out daily activities can help show the functional impact of any residuals after treatment ends.

Secondary conditions

Conditions that are often caused or made worse by this one. If you have any of these, they may be claimable as secondary service connection.